Literature DB >> 26945872

Quality assurance in cardiovascular CT: a practical guide.

S K White1, E Castellano2, N Gartland1, T Patel1, S P G Padley3, M B Rubens3, E D Nicol4.   

Abstract

Cardiovascular computed tomography (CCT) is a cutting-edge imaging technique providing important, non-invasive, diagnostic information. Concerns exist regarding radiation exposure to patient populations, but achieving optimal image quality at the lowest doses can be challenging. This guide provides practical advice about how quality can be assured in any CCT unit or radiology department. Illustrated by real-world vignettes and data analysis from our own experience, we highlight a multidisciplinary team approach to each stage of the patient journey, the effectiveness of regular dose audit overseen by a CT optimisation group, and the importance of underused systolic scanning techniques, in order to drive significant dose reduction without loss of image quality or clinical confidence. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26945872     DOI: 10.1016/j.crad.2016.01.024

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  3 in total

Review 1.  Training and Service Provision in Cardiovascular CT: International Challenges and Solutions.

Authors:  E D Nicol; J Shambrook; E Shaw; J Leipsic; L Shaw
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

2.  Impact of an ultra-low dose unenhanced planning scan on CT coronary angiography scan length and effective radiation dose.

Authors:  Laura Duerden; Helen O'Brien; Susan Doshi; Pia Charters; Laurence King; Benjamin J Hudson; Jonathan Carl Luis Rodrigues
Journal:  BJR Open       Date:  2022-09-09

3.  Image Quality and Dose Reduction by Dual Source Computed Tomography Coronary Angiography: Protocol Comparison.

Authors:  Ernesto Forte; Serena Monti; Chiara Anna Parente; Lukas Beyer; Roberto De Rosa; Teresa Infante; Carlo Cavaliere; Filippo Cademartiri; Marco Salvatore; Christian Stroszczynski; Carlo Tedeschi
Journal:  Dose Response       Date:  2018-10-16       Impact factor: 2.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.